Journal decision profile

Science Translational Medicine

Medicine

Science Translational Medicine's 2026 Journal Metrics Score is 14.8, ranking Q1 in Immunology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

American Association for the Advancement of ScienceUnited StatespISSN 1946-6234eISSN 1946-6242
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
14.8

Journal Metrics Score 2026 · 2021–2024 window citedness 17.23.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

Free preview · no sign-in

Does your manuscript fit Science Translational Medicine?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
14.82026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#114 / 1,387LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
78%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
5.15MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
—NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
327 / yr2021–2024 AVG
Field-normalized top 10% share78%

1020 of 1,308 works · same type, year & subfield

Field-normalized top 1% share18.5%

242 works · same type, year & subfield

Median FWCI5.15×

Above field-year expectation

Source output rank#114

of 1,387 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 5.15, so its typical recent paper runs about 415% above its field benchmark.

What does Top 10% Share mean?

78% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

4652016
4622017
4332018
4672019
4852020
3762021
3392022
2902023
3032024
3332025

Recent work-type mix

1,308 OpenAlex works · 2021–2024

Article96.1%
Erratum3.1%
Editorial0.5%
Review0.2%
Retraction0.1%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Science Translational Medicine publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
SARS-CoV-2 and COVID-19 Research100
CAR-T cell therapy research44
Neuroinflammation and Neurodegeneration Mechanisms29
Cancer Immunotherapy and Biomarkers27
Immune Cell Function and Interaction26
Alzheimer's disease research and treatments24
HIV Research and Treatment21
Liver Disease Diagnosis and Treatment18
Mosquito-borne diseases and control17
T-cell and B-cell Immunology17
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 1,308 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
ImmunologyQ1
OncologyQ1

Is Science Translational Medicine a good journal?

Yes. One of the most-cited journals in Medicine

Yes. By citation data, Science Translational Medicine is one of the most-cited journals in Medicine: it ranks #54 of 6,272 Medicine journals by Journal Metrics Score (top 1%) and is Q1 in Immunology and 1 other subfield. Science Translational Medicine's 2026 Journal Metrics Score is 14.8. OpenAlex classifies its papers in subfields including Immunology and Oncology, so check that your topic fits its scope.

Best quartile
Q1
Immunology
Rank in Medicine
#54 of 6,272
Top 1%
2026 Journal Metrics Score
14.8
Acceptance rate
Not published
By the journal or publisher
Papers published in 2025
333
OpenAlex works

Check before you submit

  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q1
Subfield Quartile
B1
CAS Block

Ranking and source check

#54
of 6,272 Medicine field journals
#54
among Q1 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Science journals compared

2026 Journal Metrics Scores for all 6 Science journals published by American Association for the Advancement of Science, highest score first. Each journal is scored separately; there is no combined score for the Science family.

  1. Science20.0Q1
  2. Science Robotics16.8Q1
  3. Science Immunology15.2Q1
  4. Science Translational Medicinethis journal14.8Q1
  5. Science Advances12.3Q1
  6. Science Signaling5.5Q1

Journal Details

OpenAlex Works
7,326
H-Index
364
Fully Open Access
No
Recent OA Works
2,375
Subject Areas
ImmunologyOncology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Science Translational Medicine

  1. 1

    Check the scope

    OpenAlex classifies Science Translational Medicine's papers in subfields including Immunology and Oncology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Science Translational Medicine homepage ↗
  3. 3

    Submit online

    Use the submit link in Science Translational Medicine's author guidelines; American Association for the Advancement of Science runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex has no article processing charge on record. Check the journal website for page charges or an optional open-access fee.

  5. 5

    Know what to expect

    Science Translational Medicine does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Science Translational Medicine

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Science Translational Medicine

Is Science Translational Medicine a good journal?

Yes. By citation data, Science Translational Medicine is one of the most-cited journals in Medicine: it ranks #54 of 6,272 Medicine journals by Journal Metrics Score (top 1%) and is Q1 in Immunology and 1 other subfield. Science Translational Medicine's 2026 Journal Metrics Score is 14.8. OpenAlex classifies its papers in subfields including Immunology and Oncology, so check that your topic fits its scope.

What is Science Translational Medicine's Journal Metrics Score in 2026?

Science Translational Medicine's 2026 Journal Metrics Score is 14.8, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Science Translational Medicine?

We have not found an official acceptance rate published by Science Translational Medicine or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Science Translational Medicine's quartile and score with similar journals, or ask the editorial office.

What quartile is Science Translational Medicine in?

Science Translational Medicine's best quartile is Q1. By OpenAlex subfield: Q1 in Immunology; Q1 in Oncology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Science Translational Medicine will not match this score exactly. Compare journals using one source at a time.

Which journals are alternatives to Science Translational Medicine?

Comparable journals include Clinical & Translational Immunology, Signal Transduction and Targeted Therapy, Nature Medicine, and Cell Reports Medicine. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Science Translational Medicine?

Submit online through the link in Science Translational Medicine's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.

Cite an article from this journal
Back to Search